Michiel de Vries Selected Research

1,1-dioxide 2- (4- (4- (7- chloro- 2,3- dihydro- 1,4- benzodioxin- 5- yl)- 1- piperazinyl)butyl)- 1,2-benzisothiazol-3(2H)-one

6/2002

5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michiel de Vries Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 10/2015
1	Mood Disorders (Mood Disorder) 06/2002

Drug/Important Bio-Agent (IBA)

2	enzalutamideIBA 10/2015 - 10/2015
1	1,1-dioxide 2- (4- (4- (7- chloro- 2,3- dihydro- 1,4- benzodioxin- 5- yl)- 1- piperazinyl)butyl)- 1,2-benzisothiazol-3(2H)-oneIBA 06/2002

Therapy/Procedure

2	Castration 10/2015 - 10/2015